Envoy Medical Statistics
Total Valuation
Envoy Medical has a market cap or net worth of $27.47 million. The enterprise value is $41.86 million.
Important Dates
The last earnings date was Monday, March 31, 2025, before market open.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Envoy Medical has 21.29 million shares outstanding. The number of shares has increased by 49.69% in one year.
| Current Share Class | 21.29M |
| Shares Outstanding | 21.29M |
| Shares Change (YoY) | +49.69% |
| Shares Change (QoQ) | -16.67% |
| Owned by Insiders (%) | 37.88% |
| Owned by Institutions (%) | 13.27% |
| Float | 10.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 108.57 |
| Forward PS | 77.54 |
| PB Ratio | -1.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 186.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24
| Current Ratio | 1.24 |
| Quick Ratio | 0.84 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -125.51% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -481.40% |
| Revenue Per Employee | $6,618 |
| Profits Per Employee | -$822,735 |
| Employee Count | 34 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.84% in the last 52 weeks. The beta is 2.29, so Envoy Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.29 |
| 52-Week Price Change | -66.84% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 2.18 |
| Relative Strength Index (RSI) | 39.00 |
| Average Volume (20 Days) | 18,824 |
Short Selling Information
The latest short interest is 100,309, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 100,309 |
| Short Previous Month | 104,606 |
| Short % of Shares Out | 0.47% |
| Short % of Float | 0.94% |
| Short Ratio (days to cover) | 1.75 |
Income Statement
In the last 12 months, Envoy Medical had revenue of $225,000 and -$27.97 million in losses. Loss per share was -$1.49.
| Revenue | 225,000 |
| Gross Profit | -517,000 |
| Operating Income | -19.26M |
| Pretax Income | -23.04M |
| Net Income | -27.97M |
| EBITDA | -18.04M |
| EBIT | -19.26M |
| Loss Per Share | -$1.49 |
Full Income StatementBalance Sheet
The company has $5.48 million in cash and $19.66 million in debt, giving a net cash position of -$14.18 million or -$0.67 per share.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 19.66M |
| Net Cash | -14.18M |
| Net Cash Per Share | -$0.67 |
| Equity (Book Value) | -18.84M |
| Book Value Per Share | -0.88 |
| Working Capital | 1.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.95 million and capital expenditures -$980,000, giving a free cash flow of -$18.93 million.
| Operating Cash Flow | -17.95M |
| Capital Expenditures | -980,000 |
| Free Cash Flow | -18.93M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | -229.78% |
| Operating Margin | -8,558.22% |
| Pretax Margin | -9,242.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |